- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Radiologists provide more than 'reads'
The concept that radiologists provide "reads," as opposed to professional interpretation services, is degrading to the profession and misleading to those outside of our profession. It plays into the hands of all who seek to minimize and undervalue our work.
A comment regarding the editorial by John C. Hayes, "Radiology could face disruption under 'spot market' for image reads" (September, page 5).
The concept that radiologists provide "reads," as opposed to professional interpretation services, is degrading to the profession and misleading to those outside of our profession. It plays into the hands of all who seek to minimize and undervalue our work. If we as radiologists accept this "reads" label, then we will get what we deserve-relegation to commodity status with our work farmed out to the lowest bidder.
It is contradictory to insist that we are physicians concerned with the well-being and medical care of our patients and then allow our services to be treated as an auto manufacturer (payer) might treat a car part (read) placed on a vehicle (examination) by a worker (radiologist) as it traverses an assembly line (imaging service encounter).
James B. Ball Jr., M.D.
Longwood, FL
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
